These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24836964)

  • 1. Dravet syndrome--from epileptic encephalopathy to channelopathy.
    Brunklaus A; Zuberi SM
    Epilepsia; 2014 Jul; 55(7):979-84. PubMed ID: 24836964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirming an expanded spectrum of SCN2A mutations: a case series.
    Matalon D; Goldberg E; Medne L; Marsh ED
    Epileptic Disord; 2014 Mar; 16(1):13-8. PubMed ID: 24659627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?
    Scheffer IE; Zhang YH; Jansen FE; Dibbens L
    Brain Dev; 2009 May; 31(5):394-400. PubMed ID: 19203856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCN1A testing for epilepsy: application in clinical practice.
    Hirose S; Scheffer IE; Marini C; De Jonghe P; Andermann E; Goldman AM; Kauffman M; Tan NC; Lowenstein DH; Sisodiya SM; Ottman R; Berkovic SF;
    Epilepsia; 2013 May; 54(5):946-52. PubMed ID: 23586701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Prediction Model for Early Diagnosis of
    Brunklaus A; Pérez-Palma E; Ghanty I; Xinge J; Brilstra E; Ceulemans B; Chemaly N; de Lange I; Depienne C; Guerrini R; Mei D; Møller RS; Nabbout R; Regan BM; Schneider AL; Scheffer IE; Schoonjans AS; Symonds JD; Weckhuysen S; Kattan MW; Zuberi SM; Lal D
    Neurology; 2022 Mar; 98(11):e1163-e1174. PubMed ID: 35074891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations.
    Stafstrom CE
    J Child Neurol; 2009 Aug; 24(8 Suppl):15S-23S. PubMed ID: 19666879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.
    Fujiwara T
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S223-30. PubMed ID: 16806826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dravet Syndrome: Diagnosis and Long-Term Course.
    Connolly MB
    Can J Neurol Sci; 2016 Jun; 43 Suppl 3():S3-8. PubMed ID: 27264139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.
    Brunklaus A; Ellis R; Reavey E; Forbes GH; Zuberi SM
    Brain; 2012 Aug; 135(Pt 8):2329-36. PubMed ID: 22719002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndrome.
    Mulley JC; Hodgson B; McMahon JM; Iona X; Bellows S; Mullen SA; Farrell K; Mackay M; Sadleir L; Bleasel A; Gill D; Webster R; Wirrell EC; Harbord M; Sisodiya S; Andermann E; Kivity S; Berkovic SF; Scheffer IE; Dibbens LM
    Epilepsia; 2013 Sep; 54(9):e122-6. PubMed ID: 23895530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities and predictors of health-related quality of life in Dravet syndrome.
    Brunklaus A; Dorris L; Zuberi SM
    Epilepsia; 2011 Aug; 52(8):1476-82. PubMed ID: 21668444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified.
    Zucca C; Redaelli F; Epifanio R; Zanotta N; Romeo A; Lodi M; Veggiotti P; Airoldi G; Panzeri C; Romaniello R; De Polo G; Bonanni P; Cardinali S; Baschirotto C; Martorell L; Borgatti R; Bresolin N; Bassi MT
    Arch Neurol; 2008 Apr; 65(4):489-94. PubMed ID: 18413471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study.
    Zamponi N; Passamonti C; Petrelli C; Veggiotti P; Baldassari C; Verrotti A; Capovilla G; Viri M; Coppola G; Vignoli A
    Pediatr Neurol; 2014 Mar; 50(3):228-32. PubMed ID: 24405698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
    Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
    Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCN1A-related phenotypes: Epilepsy and beyond.
    Scheffer IE; Nabbout R
    Epilepsia; 2019 Dec; 60 Suppl 3():S17-S24. PubMed ID: 31904117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.
    Ceulemans BP; Claes LR; Lagae LG
    Pediatr Neurol; 2004 Apr; 30(4):236-43. PubMed ID: 15087100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood.
    Zupanc ML
    J Child Neurol; 2009 Aug; 24(8 Suppl):6S-14S. PubMed ID: 19666878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.